Century Therapeutics
Stock Forecast, Prediction & Price Target
Century Therapeutics (IPSC) stock Price Target by analysts
$5
Potential upside: 792.85%
Century Therapeutics price prediction
What is Century Therapeutics stock analysts` prediction?
Century Therapeutics stock forecast: Based on 1 Wall Street analysts` predicted price targets for Century Therapeutics in the last 3 months, the avarage price target is $5, with a high forecast of $NaN. The average price target represents a 792.85% change from the last price of $0.56.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Century Therapeutics stock Price Target by analysts
Full breakdown of analysts given Century Therapeutics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Mitchell Kapoor H.C. Wainwright | 0% 0/1 | 11 months ago | $5 792.85% upside | $1.39 | StreetInsider | Previous targets (0) |
Edward Tenthoff Piper Sandler | 0% 0/2 | over 1 year ago | $9 1507.14% upside | $4.05 | StreetInsider | Previous targets (1) |
Edward Tenthoff Piper Sandler | 0% 0/2 | over 2 years ago | $14 2399.99% upside | $4.84 | TheFly | Previous targets (1) |
Geulah Livshits Chardan Capital | 0% 0/1 | almost 3 years ago | $19 3292.85% upside | $5.67 | TheFly | Previous targets (0) |
Unknown H.C. Wainwright | N/A | almost 3 years ago | $25 4364.28% upside | $11 | Benzinga | N/A |
Unknown Leerink Partners | N/A | over 3 years ago | $27 4721.42% upside | $12.03 | Benzinga | N/A |
Century Therapeutics Financial Estimates
Century Therapeutics Revenue Estimates
Century Therapeutics EBITDA Estimates
Century Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $5.19M 0% | $2.23M -57.01% | Avg: $13.73M Low: $409.54K High: $45.30M avg. 514.31% | Avg: $41.73M Low: $2.90M High: $140.72M avg. 203.93% | Avg: $23.2M Low: $1.61M High: $78.23M avg. -44.40% | Avg: $154.5M Low: $10.77M High: $521.02M avg. 565.94% |
Net Income
% change YoY
| $-95.82M N/A | $-130.93M -36.63% | $-136.67M -4.38% | Avg: $-139.43M Low: $-150.65M High: $-77.10M avg. -2.02% | Avg: $-125.88M Low: $-339.13M High: $17.38M avg. 9.72% | Avg: $-162.52M Low: $-663.74M High: $34.02M avg. -29.10% | Avg: $-110.91M Low: $-452.99M High: $23.22M avg. 31.75% |
EBITDA
% change YoY
| $-94.50M N/A | $-121.29M -28.34% | $-121.20M 0.07% | Avg: $2.74M Low: $81.90K High: $9.06M avg. 102.26% | Avg: $8.34M Low: $581.84K High: $28.14M avg. 203.93% | Avg: $4.63M Low: $323.47K High: $15.64M avg. -44.40% | Avg: $30.89M Low: $2.15M High: $104.20M avg. 565.94% |
EPS
% change YoY
| -$1.74 N/A | -$2.27 -30.45% | -$2.3 -1.32% | Avg: -$1.83 Low: -$2.54 High: -$1.3 avg. 20.26% | Avg: -$1.4 Low: -$5.72 High: $0.29 avg. 23.66% | Avg: -$2.74 Low: -$11.19 High: $0.57 avg. -95.71% | Avg: -$1.87 Low: -$7.64 High: $0.39 avg. 31.75% |
Operating Expenses
% change YoY
| $94.88M N/A | $139.03M 46.52% | $148.78M 7.01% | Avg: $51.67M Low: $1.54M High: $170.52M avg. -65.26% | Avg: $157.06M Low: $10.95M High: $529.69M avg. 203.93% | Avg: $87.32M Low: $6.08M High: $294.48M avg. -44.40% | Avg: $581.52M Low: $40.54M High: $1.96B avg. 565.94% |
FAQ
What is Century Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 2.58% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -150.65M, average is -139.43M and high is -77.10M.
What is Century Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 309.94% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $409.54K, average is $13.73M and high is $45.30M.
What is Century Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -5.00% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$2.54, average is -$1.83 and high is $-1.3.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Century Therapeutics stock. The most successful analyst is Mitchell Kapoor.